CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-02 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise · Non-Qualified Stock Option (right to buy) | −531 | 6,907 | ||
| 2023-02-01 | COZADD BRUCE C Chairman & CEO | Sale | −1,000 | $155.79 | $156K | 367,078 |
| 2023-01-03 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise | +531 | $109.45 | $58K | 11,840 |
| 2023-01-03 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −531 | $159.59 | $85K | 11,309 |
| 2023-01-03 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise · Non-Qualified Stock Option (right to buy) | −531 | 7,438 | ||
| 2023-01-03 | COZADD BRUCE C Chairman & CEO | Sale | −1,000 | $159.59 | $160K | 370,078 |
| 2023-01-03 | COZADD BRUCE C Chairman & CEO | Sale | −2,000 | $160.00 | $320K | 368,078 |
| 2022-12-21 | GALA RENEE D EVP & Chief Financial Officer | Sale | −2,635 | $160.00 | $422K | 32,558 |
| 2022-12-13 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise | +531 | $109.45 | $58K | 11,840 |
| 2022-12-13 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −531 | $155.45 | $83K | 11,309 |
| 2022-12-13 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise · Non-Qualified Stock Option (right to buy) | −531 | 7,969 | ||
| 2022-12-09 | Iannone Robert EVP, Global Head of R&D | Sale | −1,844 | $151.54 | $279K | 36,316 |
| 2022-12-05 | Swisher Daniel N JR President and COO | Other disposition | −10,465 | 46,984 | ||
| 2022-12-05 | Carr Patricia SVP, Chief Accounting Officer | Sale | −63 | $152.06 | $10K | 5,934 |
| 2022-12-02 | Cook Jennifer E. Director | Sale | −420 | $154.68 | $65K | 5,471 |
| 2022-12-02 | Smith Mark Douglas Director | Sale | −420 | $154.68 | $65K | 5,471 |
| 2022-12-01 | COZADD BRUCE C Chairman & CEO | Sale | −1,000 | $157.00 | $157K | 371,078 |
| 2022-11-22 | ENRIGHT PATRICK G Director | Sale | −2,905 | $149.18 | $433K | 21,181 |
| 2022-11-22 | ENRIGHT PATRICK G Director | Sale | −2,069 | $149.90 | $310K | 19,112 |
| 2022-11-22 | ENRIGHT PATRICK G Director | Sale | −2,000 | $152.88 | $306K | 0 |
Page 21 of 31 · 614 trades